Acute Asthma
18
1
1
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.6%
1 terminated out of 18 trials
93.8%
+7.2% vs benchmark
56%
10 trials in Phase 3/4
20%
3 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (18)
Dosing of Steroids for Acute Asthma Given in the Emergency Department - a Pilot Randomised Feasibility Trial of Dexamethasone in Children
Supporting Parents to Choose Wisely
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms
Magnesium Nebulization Utilization in Management of Pediatric Asthma
Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children
Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes
Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens
Budesonide Inhalation Suspension for Acute Asthma in Children
Budesonide for Emergency Treatment of Acute Wheezing in Children
Effect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children.
Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing
Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation
Heliox and Posture in Patients With Asthma